Literature DB >> 11724209

Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension.

S Harwood1, A M Mullen, A C McMahon, A Dawnay.   

Abstract

BACKGROUND: Little is known about the renal handling of endogenous ouabain-like compound (OLC). The aim of this study was to determine the normal renal clearance of OLC and the effect of mild experimental uremia on plasma OLC and its clearance.
METHODS: Male Wistar rats were studied 8 weeks after subtotal (5/6th) nephrectomy (n = 8) and compared with a control sham-operated group (n = 8).
RESULTS: Plasma creatinine and OLC were higher in uremic animals compared with controls (creatinine 76+/-5.6 micromol/L v 45+/-9.6 micromol/L, respectively, P < .00005; OLC 195+/-62 pmol/L v 121+/-62 pmol/L, P < .02). Creatinine clearance and OLC clearance were lower in uremic animals compared with controls (creatinine 1.06+/-0.12 mL/min v 1.58+/-0.32 mL/min, respectively, P < .002; OLC 23.6+/-10.4 microL/min v 33.2+/-11.4 microL/min, P < .05). There were no significant differences (all P > .05) between the uremic and control groups in the fractional clearance of OLC (uremic 2.3%+/-1.0% v control 2.2%+/-1.0%), OLC excretion rate (uremic 6.2+/-2.4 pmol/24 h v control 5.0+/-1.1 pmol/24 h) or in the mean systolic blood pressure (BP) (uremic 132+/-13 mm Hg v control 126+/-3 mm Hg). The amount of OLC excreted per unit of functioning nephron mass was 78% higher in uremic animals than in controls. The rate of tubular absorption varied linearly with filtered load, did not differ between groups, and showed no evidence of saturation.
CONCLUSIONS: The kidneys are an important excretion route for plasma OLC and moderate but significant increases may occur without inducing hypertension in the short term. The low fractional clearance of OLC is most likely due to tubular absorption and/or catabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724209     DOI: 10.1016/s0895-7061(01)02219-1

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

Review 1.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 2.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

3.  Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway.

Authors:  Syed J Khundmiri; Vishal Amin; Jeff Henson; John Lewis; Mohamed Ameen; Madhavi J Rane; Nicholas A Delamere
Journal:  Am J Physiol Cell Physiol       Date:  2007-07-18       Impact factor: 4.249

Review 4.  Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.

Authors:  Michael J Shattock; Michela Ottolia; Donald M Bers; Mordecai P Blaustein; Andrii Boguslavskyi; Julie Bossuyt; John H B Bridge; Ye Chen-Izu; Colleen E Clancy; Andrew Edwards; Joshua Goldhaber; Jack Kaplan; Jerry B Lingrel; Davor Pavlovic; Kenneth Philipson; Karin R Sipido; Zi-Jian Xie
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

Review 5.  On the Many Actions of Ouabain: Pro-Cystogenic Effects in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Jessica Venugopal; Gustavo Blanco
Journal:  Molecules       Date:  2017-05-03       Impact factor: 4.411

Review 6.  Cardiotonic Steroids and the Sodium Trade Balance: New Insights into Trade-Off Mechanisms Mediated by the Na⁺/K⁺-ATPase.

Authors:  Fatimah K Khalaf; Prabhatchandra Dube; Amal Mohamed; Jiang Tian; Deepak Malhotra; Steven T Haller; David J Kennedy
Journal:  Int J Mol Sci       Date:  2018-08-30       Impact factor: 5.923

Review 7.  Endogenous cardiotonic steroids and cardiovascular disease, where to next?

Authors:  Davor Pavlovic
Journal:  Cell Calcium       Date:  2019-12-27       Impact factor: 6.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.